↑

International Patients: +91 8743024344 · Indian Patients: +91 7838223336 · Patient Reviews · Leave a Google Review ★

Critical Limb Ischemia · Stem Cell Therapy

Critical Limb Ischemia Stem Cell Treatment in Delhi, India

Stem cell therapy for Critical Limb Ischemia is an investigational approach being studied alongside standard medical care, with potential benefits varying depending on the type and severity of the injury.

Get Free Medical Evaluation → · Upload Medical Reports → · Latest Blog on Critical Limb Ischemia →

10,000+ patients treated worldwide
Stem Cell Care India doctor reviewing before-and-after brain scans on a tablet with a patient and family member during a critical limb ischemia stem cell therapy consultation
10,000+ Patients treated
65+ Countries served
Certified Accredited hospitals & labs
16+ Years GMP-certified cell processing

Quick Answer

Stem cells are being evaluated in critical limb ischemia for their angiogenic properties, which may help form collateral vessels and lower the risk of tissue necrosis. Evidence to date is moderate, and personal evaluation by a vascular specialist is necessary before combining stem cell therapy with other limb-salvage treatments.

Key Takeaways

On this page — 6 categories, 27 topics

01

What Stem Cell Therapy for Critical Limb Ischemia Is

Critical Limb Ischemia (CLI) is the most severe form of peripheral artery disease, in which arteries supplying the legs, feet or hands become so narrowed or blocked that blood flow can no longer meet the tissue’s basic needs. This can lead to severe pain, non-healing ulcers, and, in advanced cases, gangrene, making prompt treatment essential.

CLI is closely linked to diabetes, smoking, high blood pressure, high cholesterol, obesity and a sedentary lifestyle. Standard treatment options include revascularisation (bypass surgery or angioplasty), medication, and, when tissue loss is severe, amputation. Stem cell therapy for CLI is offered as a supportive, investigational option aimed at improving blood flow and supporting wound healing alongside these established approaches.

02

Symptoms of Critical Limb Ischemia

  • Gangrene in advanced cases
  • Thickened toenails
  • Weak or absent pulses in the legs or feet
  • Slow-healing or non-healing sores, infections or ulcers on the toes or feet
  • Noticeably cooler skin temperature in the affected limb
  • Severe pain or numbness at rest (rest pain)
  • Shiny, smooth, dry skin on the legs or feet
03

Types of Critical Limb Ischemia

CLI is generally staged by severity:

Stage 1 — Asymptomatic: Little or no noticeable symptoms; severity is low at this point.

Stage 2 — Intermittent Claudication: Muscle pain during activity, which can initially be mistaken for ordinary exertion.

Stage 3 — Ischemic Rest Pain: Burning pain in the foot and toes that worsens at night, signalling a more serious stage.

Stage 4 — Ulceration or Gangrene: The most severe stage, marked by skin breakdown and tissue death from insufficient blood flow.

04

Causes of Critical Limb Ischemia

CLI results from advanced atherosclerosis — a gradual thickening and narrowing of the arteries caused by plaque buildup — restricting or blocking blood flow to the legs, feet or hands. Key risk factors include:

  • Age (men over 60, women after menopause)
  • Smoking, present in a large majority of peripheral artery disease patients
  • Diabetes, which can raise CLI risk substantially
  • Overweight or obesity
  • A sedentary lifestyle
  • High cholesterol (dyslipidemia)
  • High blood pressure
  • Family history of vascular disease
05

How Critical Limb Ischemia Is Diagnosed

Diagnosis begins with a physical examination checking skin colour, temperature and pulses, followed by targeted tests:

Ankle-Brachial Index (ABI): Compares ankle and arm blood pressure; a value below 0.4 typically indicates severe ischemia.

Toe-Brachial Index (TBI): Useful in diabetic patients where ABI may be inaccurate due to vessel calcification.

Transcutaneous Oxygen Pressure (TcPO2): Assesses tissue oxygenation and can help predict wound healing potential.

Duplex Ultrasound: Combines standard ultrasound with Doppler imaging to visualise blood flow and blockages.

Angiography: The gold-standard imaging test, precisely locating blockages to guide surgical or endovascular treatment decisions.

06

How Stem Cell Therapy Is Approached as a Treatment for Critical Limb Ischemia

Standard treatment for CLI centres on relieving pain, healing ulcers and restoring blood flow through revascularisation, though not every patient is a suitable surgical candidate and amputation risk remains significant in severe cases. Stem cell-based approaches are being studied for their potential to encourage new blood vessel formation and support the body’s natural repair and anti-inflammatory processes in ischemic tissue.

07

How It's Being Explored for Critical Limb Ischemia

Stem cell approaches for neurological conditions are being explored for their potential to support the body's own repair signaling around damaged nerve tissue, reduce local inflammation, and provide trophic (nourishing) support to stressed neurons and glial cells. This is being studied as a supportive, investigational approach alongside standard neurology care — not a replacement for it.

What this means in practice

For patients considering Critical Limb Ischemia care, this means stem cell therapy is discussed as one possible supportive option within a broader, physician-guided treatment plan — never as a stand-alone substitute for established neurological disorders care.

Proposed mechanism

Stem cell approaches for traumatic critical limb ischemia (TBI) research concentrate on the secondary critical limb ischemia — the biochemical and physiological cascade that can ultimately lead to neuronal cell death. Recent research has pointed to several possible mechanisms behind any potential therapeutic benefit:

  1. Secreting growth factors that may encourage a functional result after critical limb ischemia through neurogenesis and synaptogenesis.
  2. Producing and inducing various cytokines and trophic factors that may augment angiogenesis and vascular stabilization in the lesion boundary zone.
  3. Reducing glial scar formation and encouraging glial-axonal remodeling.
  4. Differentiating into cells of neural origin, including neurons, astrocytes, and glial cells.

Stem cells are consequently thought to act in a pleiotropic way to encourage brain remodeling after injury by potentially influencing several neural restorative functions such as synaptogenesis, angiogenesis, and neurogenesis. These remain investigational mechanisms under active study rather than established, proven effects.

08

What the Critical Limb Ischemia Treatment Process Looks Like

Typical Treatment Timeline

Day 1: Airport pickup, doctor consultation, admission, clinical examination and lab work, and supportive therapy.

Day 2: The stem cell procedure, supportive therapies and physiotherapy.

Day 3: Further supportive therapy and physiotherapy, discharge, and airport drop-off.

09

Delivery Techniques Used in Stem Cell Therapy for Critical Limb Ischemia

Stem cells may be delivered through intravenous administration, intrathecal (lumbar puncture) injection, intramuscular or subcutaneous injection, intra-arterial delivery, or surgical administration in more severe cases.

10

Changes Critical Limb Ischemia Patients Sometimes Report

  • Improved blood circulation and oxygen supply to affected tissue
  • Faster healing of chronic ulcers and sores
  • Reduced rest pain
  • Better walking capacity
  • Less swelling and numbness
  • Reduced risk of further tissue injury
  • Improved skin appearance and warmth in the affected limb
11

Is Stem Cell Therapy Safe for Critical Limb Ischemia?

Stem cell therapy for Critical Limb Ischemia is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Critical Limb Ischemia, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

12

Who Might Consider a Critical Limb Ischemia Discussion — and Who Should Not

May be reasonable to discuss

  • A confirmed critical limb ischemia diagnosis, with the patient medically stable and not in an acute emergency
  • Prior imaging, neurology, and treatment records available for review
  • The injury is past its acute phase, with the patient in a stable, chronic-care stage
  • Realistic expectations that any benefit would be supportive and investigational, not a cure
  • Willingness to continue rehabilitation and follow-up care alongside this discussion

Generally not appropriate

  • Acute or unstable neurological emergencies requiring immediate critical care
  • Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
  • An active, untreated malignancy that has not been cleared by an oncologist
  • Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
  • Unwillingness to share prior medical records or to be evaluated before proceeding

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

13

What a Critical Limb Ischemia Supportive-Care Discussion Involves

A supportive-care discussion for Critical Limb Ischemia isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

  1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Critical Limb Ischemia are reviewed by the medical team first.
  2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
  3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
  4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
  5. Ongoing standard care continues: At every stage, your prescribed treatment for Critical Limb Ischemia continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

14

Our Approach to Critical Limb Ischemia Care

Stem Cell Care India describes a commitment to working only with qualified, experienced specialists, maintaining a compassionate treatment environment, and offering flexible payment options so patients can pursue treatment without undue financial strain.

15

Cost and How Stem Cell Therapy Compares for Critical Limb Ischemia

Cost is affected by the severity of the condition, the patient’s medical history, the number of stem cells required, and the patient’s age and general health. A free consultation is recommended to establish costs and expectations before treatment begins.

16

What Influences Critical Limb Ischemia Outcomes

Reported clinic observations include improved vessel tissue regeneration, better angiogenesis, reduced pain, faster wound healing, and improved self-regulation of symptoms in some patients following treatment, though these are individual clinic reports rather than results from large controlled trials.

17

Why Critical Limb Ischemia Patients Consider Treatment in India

  • Typically involves only a short hospital stay
  • Uses quality-controlled, screened cell sources
  • Comprehensive support offered throughout the decision and treatment process
18

Quality Control in Cell Processing for Critical Limb Ischemia Therapy

  • All cells are screened for infection before use in therapy
  • Gram testing is performed at multiple stages
  • Culture media are tested to ensure safety
  • A final wash of the stem cell source is checked for aerobic and anaerobic microbes
  • Endotoxin testing ensures only batches below a set threshold qualify for use
  • Each batch is accompanied by a Certificate of Analysis
19

What Critical Limb Ischemia Patients May Notice After Treatment

A study from a vascular surgery unit at the University of Crete, Greece, examining autologous mesenchymal cell treatment in patients facing possible amputation, reported that three of six treated patients improved enough to avoid amputation, with the ankle-brachial pressure index improving by roughly 29% on average and reported leg pain decreasing by around 22% after treatment. Outcomes were less favourable in patients with more extensive superficial femoral artery narrowing, illustrating how results vary with disease severity.

20

Critical Limb Ischemia Patient Experiences

Maribel V. Bowser (Asheville, North Carolina): Sought treatment for a worsening leg vein issue after researching costs, and reports feeling notably better within days of the procedure.

Manohar Shrivastava (Lucknow, India): Describes a severe circulation problem that put his leg’s future in doubt, and reports being able to walk again after treatment at the clinic.

Drishti Sharma (Mumbai, India): Chose stem cell treatment over surgery due to concerns about pain and medication, and reports the pain resolving over time without needing amputation.

21

Quality Certification for Critical Limb Ischemia Therapy

A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.

The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Critical Limb Ischemia, and a supporting team of medical staff is described as being available throughout the process.

22

Critical Limb Ischemia Follow-Up Care

The clinic states that its staff contact patients at one month, two months and six months after treatment to assess progress and refine its protocols, with further support available on request.

23

Supportive Therapies Sometimes Used Alongside Critical Limb Ischemia Treatment

  • Nutrition therapy emphasising antioxidant-rich foods to support circulation and healing
  • Diet counselling tailored to related conditions such as diabetes or hypertension
  • Physiotherapy to rebuild strength, mobility and balance
  • Rehabilitation therapy to support independence in daily activities
24

Why Some International Critical Limb Ischemia Patients Consider India

International patients cite lower treatment costs, modern medical infrastructure, comprehensive care packages, favourable medical tourism policies, and personalised treatment plans as reasons for pursuing CLI-related stem cell therapy in India.

25

Conclusion: Stem Cell Therapy for Critical Limb Ischemia

Topic 25 of 25

Critical Limb Ischemia is a dangerous vascular condition that can threaten limb viability without prompt attention, and its risk factors — diabetes, smoking, high blood pressure, high cholesterol and obesity — are largely addressable through lifestyle change.

Stem cell therapy is being explored as a supportive option aimed at improving circulation and supporting tissue healing, but it should be viewed as an adjunct to, not a replacement for, established revascularisation and wound care.

Early medical attention, combined with smoking cessation and consistent follow-up, gives patients the best chance of preserving limb function.

Still deciding? ★★★★★ 4.9/5 from 193+ verified patients A free medical review shows whether it's worth pursuing for your specific case — no obligation.

Not sure if this applies to your case?

Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Critical Limb Ischemia — no obligation.

  • Reviewed by our in-house medical team
  • Doctor-reviewed reply within 24–48 hours
  • No cost and no obligation to proceed
  • Your information is kept confidential

Get Your Free Evaluation

1. Your details 2. Your case
Common Questions

Frequently Asked Questions

The most severe and progressive stage of peripheral artery disease, in which patients experience significant pain at rest due to very poor blood flow, and which can progress to gangrene and limb loss if untreated.

Adult stem cells from the patient’s own adipose tissue or bone marrow are being studied for their ability to support tissue repair, encourage revascularisation around blocked arteries, and improve blood flow.

Results, where seen, vary by patient, and long-term vessel repair depends heavily on lifestyle factors such as complete smoking cessation and ongoing monitoring.

Age, smoking, obesity, diabetes, high blood pressure, and high cholesterol.

Through medication, angioplasty, bypass surgery, or amputation in advanced cases; conventional treatment does not guarantee reversal of existing tissue damage and carries its own risks.

Not fully sure which diagnosis fits? Send both reports and our medical team will confirm which condition applies — often within 24–48 hours.

If a caregiver or patient you know is dealing with a different diagnosis, this covers the same treatment approach for another common condition:

All Treatments

Explore Other Categories

Editorial & Medical Standards

Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.


Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 193+ verified Google reviews

Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 196+ verified Google reviews

Patient stories — Kidney & Liver

Priyansh Tiwari From Madhya Pradesh Came For Stem Cell Therapy For CKD Treatment

Patient with Liver Disease shares his Experience

Patient with Chronic Liver Disease shares her Experience

patient Shares his experience for Chronic kidney Disease Treatment

See all patient videos →